Patents Assigned to LEIUTIS PHARMACEUTICALS PVT. LTD.
  • NOVEL LEVOTHYROXINE FORMULATIONS FOR ORAL USE
    Publication number: 20220249362
    Abstract: The present invention relates to novel oral spray formulations of Levothyroxine. Further the invention also describes process for preparing such formulations.
    Type: Application
    Filed: April 28, 2022
    Publication date: August 11, 2022
    Applicant: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota CHANDRASHEKHAR, Banda NAGARAJU
  • Triple combination formulations for antiemetic therapy
    Patent number: 11364229
    Abstract: The disclosure relates to chemotherapy treatments and in particular, formulations for antiemetic therapy. Parenteral formulations comprising Palonosetron, NK1 receptor antagonist and a corticosteroid is provided. Also provided is a process of preparing such formulations.
    Type: Grant
    Filed: February 20, 2020
    Date of Patent: June 21, 2022
    Assignee: LEIUTIS PHARMACEUTICALS PVT, LTD
    Inventors: Chandrashekhar Kocherlakota, Nagaraju Banda
  • Levothyroxine formulations for oral use
    Patent number: 11364196
    Abstract: The present invention relates to novel oral spray formulations of Levothyroxine. Further the invention also describes process for preparing such formulations.
    Type: Grant
    Filed: November 3, 2016
    Date of Patent: June 21, 2022
    Assignee: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota Chandrashekhar, Banda Nagaraju
  • Stabilized liquid formulation of levothyroxine
    Patent number: 11154498
    Abstract: The present invention relates to stabilized liquid formulations of Levothyroxine or a pharmaceutically acceptable salt thereof, intended for parenteral administration. Further this invention also describes process of preparing such compositions.
    Type: Grant
    Filed: July 20, 2016
    Date of Patent: October 26, 2021
    Assignee: Leiutis Pharmaceuticals PVT. LTD.
    Inventors: Kocherlakota Chandrashekhar, Banda Nagaraju
  • STABLE READY TO USE CYCLOPHOSPHAMIDE LIQUID FORMULATIONS
    Publication number: 20210220375
    Abstract: The present invention relates to stable ready to use liquid formulations of Cyclophosphamide for parenteral use. The ready to use composition comprises Cyclophosphamide dissolved in a solvent system comprising a solvent, cosolvent(s) and antioxidant(s).
    Type: Application
    Filed: April 6, 2021
    Publication date: July 22, 2021
    Applicant: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota CHANDRASHEKHAR, Banda Nagaraju
  • Stable ready to use cyclophosphamide liquid formulations
    Patent number: 10993952
    Abstract: The present invention relates to stable ready to use liquid formulations of Cyclophosphamide for parenteral use. The ready to use composition comprises Cyclophosphamide dissolved in a solvent system comprising a solvent, cosolvent(s) and antioxidant(s).
    Type: Grant
    Filed: February 15, 2016
    Date of Patent: May 4, 2021
    Assignee: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota Chandrashekhar, Banda Nagaraju
  • LIQUID FORMULATIONS OF FOSAPREPITANT
    Publication number: 20200188406
    Abstract: The present invention relates to liquid formulations of Fosaprepitant intended for parenteral administration. Further the invention also describes process for preparing such formulations.
    Type: Application
    Filed: February 26, 2020
    Publication date: June 18, 2020
    Applicant: Leiutis Pharmaceuticals PVT. LTD.
    Inventors: Kocherlakota CHANDRASHEKHAR, Banda NAGARAJU
  • Liquid formulations of fosaprepitant
    Patent number: 10610532
    Abstract: The present invention relates to liquid formulations of Fosaprepitant intended for parenteral administration. Further the invention also describes process for preparing such formulations.
    Type: Grant
    Filed: August 2, 2016
    Date of Patent: April 7, 2020
    Assignee: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota Chandrashekhar, Banda Nagaraju
  • STABLE LIQUID FORMULATIONS OF MELPHALAN
    Publication number: 20200085731
    Abstract: The present invention relates to stable, liquid parenteral formulations of Melphalan or pharmaceutically acceptable salts thereof. Further this invention also describes process of preparing such formulations.
    Type: Application
    Filed: November 25, 2019
    Publication date: March 19, 2020
    Applicant: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota CHANDRASHEKHAR, Banda NAGARAJU
  • Stable liquid formulations of melphalan
    Patent number: 10537520
    Abstract: The present invention relates to stable, liquid parenteral formulations of Melphalan or pharmaceutically acceptable salts thereof. Further this invention also describes process of preparing such formulations.
    Type: Grant
    Filed: June 29, 2016
    Date of Patent: January 21, 2020
    Assignee: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota Chandrashekhar, Banda Nagaraju
  • PHARMACEUTICAL FORMULATIONS OF REGADENOSON
    Publication number: 20190240247
    Abstract: The present invention relates to parenteral pharmaceutical formulation of Regadenoson comprising of Regadenoson, one or more cyclodextrins and pharmaceutically acceptable excipients.
    Type: Application
    Filed: August 31, 2017
    Publication date: August 8, 2019
    Applicant: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota CHANDRASHEKHAR, Banda NAGARAJU
  • STABLE LIQUID FORMULATIONS OF PEMETREXED
    Publication number: 20190224202
    Abstract: The present invention provides a stable ready to use liquid parenteral formulations of Pemetrexed or a pharmaceutically acceptable salt thereof. Further this invention also describes process of preparing such formulations.
    Type: Application
    Filed: June 9, 2016
    Publication date: July 25, 2019
    Applicant: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota CHANDRASHEKHAR, Banda NAGARAJU
  • STABLE LIQUID PHARMACEUTICAL FORMULATIONS OF BENDAMUSTINE
    Publication number: 20190151234
    Abstract: The present invention relates to stable liquid pharmaceutical formulation of Bendamustine or a pharmaceutically acceptable salt thereof; wherein the formulation is devoid of propylene glycol.
    Type: Application
    Filed: March 30, 2017
    Publication date: May 23, 2019
    Applicant: Leiutis Pharmaceuticals Pvt. Ltd.
    Inventors: Kocherlakota CHANDRASHEKHAR, Banda NAGARAJU
  • NOVEL LEVOTHYROXINE FORMULATIONS FOR ORAL USE
    Publication number: 20190060217
    Abstract: The present invention relates to novel oral spray formulations of Levothyroxine. Further the invention also describes process for preparing such formulations.
    Type: Application
    Filed: November 3, 2016
    Publication date: February 28, 2019
    Applicant: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota CHANDRASHEKHAR, Banda NAGARAJU
  • LIQUID FORMULATIONS OF FOSAPREPITANT
    Publication number: 20180235973
    Abstract: The present invention relates to liquid formulations of Fosaprepitant intended for parenteral administration. Further the invention also describes process for preparing such formulations.
    Type: Application
    Filed: August 2, 2016
    Publication date: August 23, 2018
    Applicant: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota CHANDRASHEKHAR, Banda NAGARAJU
  • STABLE LIQUID FORMULATIONS OF MELPHALAN
    Publication number: 20180193255
    Abstract: The present invention relates to stable, liquid parenteral formulations of Melphalan or pharmaceutically acceptable salts thereof. Further this invention also describes process of preparing such formulations.
    Type: Application
    Filed: June 29, 2016
    Publication date: July 12, 2018
    Applicant: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota CHANDRASHEKHAR, Banda NAGARAJU
  • STABLE LIQUID PHARMACEUTICAL COMPOSITIONS OF BORTEZOMIB
    Publication number: 20180110822
    Abstract: The present invention relates to stable liquid pharmaceutical compositions of Bortezomib or a pharmaceutically acceptable salt thereof. Further the present invention relates to liquid parenteral formulations of Bortezomib comprising of Bortezomib, one or more solvents and other pharmaceutically acceptable adjuvants thereof.
    Type: Application
    Filed: April 12, 2016
    Publication date: April 26, 2018
    Applicant: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota CHANDRASHEKHAR, Banda NAGARAJU
  • STABLE READY TO USE CYCLOPHOSPHAMIDE LIQUID FORMULATIONS
    Publication number: 20180055861
    Abstract: The present invention relates to stable ready to use liquid formulations of Cyclophosphamide for parenteral use. The ready to use composition comprises Cyclophosphamide dissolved in a solvent system comprising a solvent, cosolvent(s) and antioxidant(s).
    Type: Application
    Filed: February 15, 2016
    Publication date: March 1, 2018
    Applicant: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota CHANDRASHEKHAR, Banda NAGARAJU